Literature DB >> 4875378

Transethmoidal drainage and arrest of craniopharyngioma by Zenker's solution. (Case report).

H H Gass, S Klein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4875378     DOI: 10.1007/BF01402538

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


× No keyword cloud information.
  9 in total

1.  RADIOACTIVE BISMUTH PHOSPHATE FOR THE TREATMENT OF CRANIOPHARYNGIOMA.

Authors:  E LINDGREN; G WESTBERG
Journal:  Acta Radiol Ther Phys Biol       Date:  1964-04

2.  RECURRENT CYSTIC FORMATION IN CRANIOPHARYNGIOMA TREATED WITH RADIOACTIVE CHROMIC PHOSPHATE. CASE REPORT.

Authors:  M C OVERTON; D D SHEFFEL
Journal:  J Neurosurg       Date:  1963-08       Impact factor: 5.115

3.  [ON THE USE OF COLLOIDAL RADIOACTIVE ISOTOPES FOR RADIOTHERAPY OF CRANIOPHARYNGIOMA].

Authors:  A A VOLKOV; I S VASKIN; M M ZOBINA; N K MURATKHODZHAEV
Journal:  Med Radiol (Mosk)       Date:  1963-07

4.  EXPERIENCES WITH RADIOACTIVE GOLD IN THE TREATMENT OF CRANIOPHARYNGIOMA.

Authors:  W H BOND; D RICHARDS; E TURNER
Journal:  J Neurol Neurosurg Psychiatry       Date:  1965-02       Impact factor: 10.154

5.  A survey of the results of treatment of intracranial tumours in recent years.

Authors:  J BRICE
Journal:  Guys Hosp Rep       Date:  1958

6.  Visualization and treatment of cystic brain tumors by stereo-encephalotomy.

Authors:  F MURTAGH; R ROBBINS; E A SPIEGEL; M SPIEGEL-ADOLF; H T WYCIS
Journal:  Acta radiol       Date:  1956 Jul-Aug       Impact factor: 1.990

7.  Studies in stereoencephalotomy III; treatment of a cystic craniopharyngioma by injection of radioactive P32.

Authors:  H T WYCIS; R ROBBINS; M SPIEGELADOLF; J MESZAROS; E A SPIEGEL
Journal:  Confin Neurol       Date:  1954

8.  Acoustic tumors.

Authors:  H Olivecrona
Journal:  J Neurosurg       Date:  1967-01       Impact factor: 5.115

9.  Radioactive chromic phosphate in cystic brain tumors.

Authors:  M C Overton
Journal:  J Nucl Med       Date:  1966-08       Impact factor: 10.057

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.